Drawing for RETROPHIN

USPTO serial 88304135

RETROPHIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CASTRO, GIANCARLO
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RETROPHIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jared Barrett

Jared Barrett SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104

Goods and services

ClassDescriptionStatusFirst use
042Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 8, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 8, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 23, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2020EX1GSOU EXTENSION 1 GRANTED—
Jul 17, 2020EXT1SOU EXTENSION 1 FILED—
Jul 17, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 10, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 1, 2019ALIEASSIGNED TO LIE—
Oct 28, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2019EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 29, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 29, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 29, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 26, 2019DOCKASSIGNED TO EXAMINER—
Mar 21, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance